would make sense for Berkshire to purchase Keryx for a couple billion as the revenue stream would be great for their bottom line over the next 10 years
unlike other biotechs I have been in, I have faith in this CEO to make the right buisness decisions....I think this guy knows how to make money..I do not think he has an ego problem...I think he is about making money...
if their assessment of future revenue is even close and the price could be quadruple what it is now based on those future projected earnings (assume that they are correct not that they are wrong) wouldn't a big guy be willing to pay 25/share at least for that kind of revenue? thank you
the analysts agree that the value of the company is in the 20's; I would take 22 dollars and no risk as well